
Moss Adams LLP also appointed as new independent registered public accounting firm. May 09, 2023 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., May 09, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc….
Moss Adams LLP also appointed as new independent registered public accounting firm. May 09, 2023 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., May 09, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc….
Study Data Highlights New Vivos Treatment Option is Highly Effective in Treating Migraine Headaches, One of the World’s Most Common Illnesses May 01, 2023 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON,…
2022 and Early 2023 Accomplishments, Including Capital Raise, Cost Reductions and New Technology Acquisition, Set the Stage for Potential 2023 Revenue Growth Management to Host Conference Call Today at 5:00…
LITTLETON, Colo., March 08, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical device and technology company that delivers training and a full line of highly…
Acquisition Adds Complementary, Lower Cost Products for Treating Conditions Associated with Obstructive Sleep Apnea LITTLETON, Colo., March 01, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical…
LITTLETON, Colo., Feb. 21, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered…